Itron (NASDAQ:ITRI) Sets New 52-Week Low – Should You Sell?

Itron, Inc. (NASDAQ:ITRI) shares hit a new 52-week low during trading on Tuesday . The company traded as low as $82.31 and last traded at $79.0530, with a volume of 23851 shares traded. The stock had previously closed at $86.92.

Key Headlines Impacting Itron

Here are the key news stories impacting Itron this week:

• Positive Sentiment: Q1 results topped expectations — Itron posted EPS of $1.49 and revenue of $586.98M, beating consensus and showing healthy margins (net margin ~12.7%, ROE ~20%). This demonstrates near-term profitability and beat-driven upside potential. Read More.
• Positive Sentiment: Company released formal Q1 press materials and slide deck for investors (useful for digging into segment performance, backlog and cash flow). Read More.
• Neutral Sentiment: Earnings call transcript is available for management commentary and Q&A — investors should review for color on order trends, margin drivers and cadence of deployments. Read More.
• Negative Sentiment: Q2 guidance came in well below Street expectations: EPS guidance of $1.25–1.35 vs. consensus ~1.45 and revenue guidance $560–570M vs. consensus ~$605.8M — the lowered outlook is the primary catalyst for the share decline. Read More.
• Negative Sentiment: Itron disclosed a mid‑April cyberattack on internal systems; management says operations were unaffected but the breach raises execution and reputational risk that could affect customer contracts and remediation costs. Read More.
• Negative Sentiment: Underlying revenue was down ~3.3% year-over-year and EPS edged below last year’s quarter ($1.49 vs. $1.52), highlighting uneven top-line trends despite the beat. Read More.

Wall Street Analysts Forecast Growth

A number of research analysts have recently weighed in on the company. Johnson Rice raised Itron from an “accumulate” rating to a “buy” rating and set a $130.00 price objective on the stock in a report on Monday, January 5th. JPMorgan Chase & Co. decreased their target price on Itron from $133.00 to $113.00 and set an “overweight” rating for the company in a report on Thursday, April 16th. Robert W. Baird set a $128.00 target price on Itron and gave the company an “outperform” rating in a research report on Wednesday, February 18th. Zacks Research raised shares of Itron from a “strong sell” rating to a “hold” rating in a research report on Thursday, February 26th. Finally, Guggenheim set a $155.00 price objective on shares of Itron in a research note on Friday, February 13th. Eight investment analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $133.10.

Itron Price Performance

The firm has a market cap of $3.77 billion, a PE ratio of 13.11, a price-to-earnings-growth ratio of 0.78 and a beta of 1.50. The stock has a 50 day simple moving average of $92.95 and a two-hundred day simple moving average of $99.92. The company has a debt-to-equity ratio of 0.45, a quick ratio of 1.56 and a current ratio of 1.80.

Itron (NASDAQ:ITRI) last issued its earnings results on Tuesday, April 28th. The scientific and technical instruments company reported $1.49 EPS for the quarter, topping analysts’ consensus estimates of $1.25 by $0.24. The firm had revenue of $586.98 million for the quarter, compared to the consensus estimate of $572.13 million. Itron had a return on equity of 20.04% and a net margin of 12.72%.The company’s revenue was down 3.3% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.52 earnings per share. Itron has set its Q2 2026 guidance at 1.250-1.350 EPS. Sell-side analysts expect that Itron, Inc. will post 5.98 earnings per share for the current year.

Insiders Place Their Bets

In related news, SVP Donald L. Reeves III sold 519 shares of the business’s stock in a transaction on Wednesday, February 25th. The shares were sold at an average price of $97.84, for a total value of $50,778.96. Following the completion of the transaction, the senior vice president directly owned 29,951 shares in the company, valued at $2,930,405.84. The trade was a 1.70% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CAO David Marshall Wright sold 264 shares of the stock in a transaction on Friday, February 20th. The stock was sold at an average price of $100.17, for a total transaction of $26,444.88. Following the sale, the chief accounting officer directly owned 9,124 shares in the company, valued at $913,951.08. This trade represents a 2.81% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last quarter, insiders have sold 51,180 shares of company stock worth $5,085,475. Corporate insiders own 1.77% of the company’s stock.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of the company. Impax Asset Management Group plc boosted its stake in shares of Itron by 127.3% during the 3rd quarter. Impax Asset Management Group plc now owns 1,588,950 shares of the scientific and technical instruments company’s stock worth $197,153,000 after acquiring an additional 890,040 shares in the last quarter. Norges Bank purchased a new position in shares of Itron in the 4th quarter valued at about $63,990,000. Soros Fund Management LLC acquired a new position in Itron in the 4th quarter worth about $34,843,000. Millennium Management LLC raised its holdings in Itron by 269.3% in the 4th quarter. Millennium Management LLC now owns 506,867 shares of the scientific and technical instruments company’s stock worth $47,068,000 after purchasing an additional 369,617 shares during the period. Finally, Merewether Investment Management LP boosted its position in Itron by 1,552.7% during the second quarter. Merewether Investment Management LP now owns 300,787 shares of the scientific and technical instruments company’s stock worth $39,593,000 after purchasing an additional 282,587 shares in the last quarter. Institutional investors and hedge funds own 96.19% of the company’s stock.

Itron Company Profile

Itron, Inc (NASDAQ: ITRI) is a global technology company that develops innovative solutions to measure, manage and analyze the use of energy and water. Its comprehensive portfolio includes smart meters, data collection devices, communication networks and advanced software applications designed to optimize utility operations and foster sustainable resource management. The company’s offerings enable utilities and cities to accurately monitor consumption patterns, streamline billing processes and improve grid reliability.

Itron’s product lineup spans a range of hardware and software solutions, from residential and commercial smart meters to meter data management systems (MDMS), networked communication platforms and analytics tools.